Rio Tinto (ADR) vs Relay Therapeutics Inc. Common Stock — how do they compare? Rio Tinto (ADR) trades at $94.77 (market cap $150.89B), while Relay Therapeutics Inc. Common Stock trades at $17.46 (market cap $3.82B). The key difference: Rio Tinto (ADR) is far larger — about 39.5× Relay Therapeutics Inc. Common Stock's market cap, and Rio Tinto (ADR) pays a 4.98% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rio Tinto (ADR) for 10 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| RIO | RLAY | |
|---|---|---|
Market Cap | $150.89B | $3.82B |
Volume | 1,492,444 | 4,332,079 |
Sector | Basic Materials | Health |
52-Week High | $112.04 | $20.75 |
52-Week Low | $65.44 | $6.03 |
Typical Hold Time | 10 Days | 0 Days |
Enterprise Value | $164.24B | $2.93B |
Dividend Yield | 4.98% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →